Clinical and Experimental Medicine is a leading journal published by Springer-Verlag Italia SRL, dedicated to advancing the understanding of the intricate relationships between biomedical research and clinical applications. Since its inception in 2001, the journal has garnered an esteemed reputation, achieving Q1 quartile rankings in 2023 in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Medicine (miscellaneous), establishing itself as a key resource for researchers and practitioners alike. With an impactful contribution reflected in its Scopus rankings, particularly a #81/221 rank in the General Biochemistry, Genetics and Molecular Biology category, Clinical and Experimental Medicine serves as a rich platform for peer-reviewed articles that bridge theory and practice across diverse medical disciplines. The journal embraces Open Access options, broadening the accessibility of groundbreaking research to a global audience, thereby fostering collaboration and innovation. Located in Milan, Italy, it continually endeavors to enrich knowledge and share valuable insights essential for the advancement of health sciences.

Therapeutic Advances in Chronic Disease is a distinguished open-access journal published by SAGE Publications Ltd, with a focus on innovative research and clinical practices addressing chronic diseases—a field increasingly relevant in today's healthcare landscape. Since its inception in 2010, the journal has committed itself to disseminating high-quality research that informs both theory and practice. With an impressive impact factor and ranked Q1 in Medicine (miscellaneous) in 2023, this journal boasts recognition as one of the top-tier publications in the medical community, placing it in the 79th percentile among its peers. Accessible since 2019, it aims to bridge the gap between cutting-edge research and its application in improving patient outcomes, inviting contributions from researchers, clinicians, and health professionals. The journal's comprehensive scope encompasses various aspects of chronic disease management, making it an invaluable resource for those seeking to advance their understanding of this critical field.

JAMA Internal Medicine is a premier scholarly journal published by the American Medical Association, renowned for its rigorous peer-review process and commitment to advancing the field of internal medicine. With an impressive impact factor that positions it in the upper echelon of medical journals, specifically ranked at Q1 in Internal Medicine and holding a remarkable Scopus rank of #2 out of 167, the journal provides a vital platform for original research, reviews, and enlightening discussions that shape clinical practices and policies. As an accessible repository of cutting-edge findings and comprehensive analyses, JAMA Internal Medicine offers both subscription and open access options, ensuring that the latest developments in medicine are available to clinicians, researchers, and the academic community at large. With its focus spanning from 2013 to 2024 and its dedication to high-quality scholarship, the journal serves as an essential resource for those seeking to enhance their understanding of the complexities of internal medicine and improve patient care.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE is a premier peer-reviewed academic journal published by WILEY-HINDAWI, dedicated to advancing the field of clinical medicine. With an ISSN of 1368-5031 and E-ISSN 1742-1241, this open access journal has been providing a platform for insightful research since its inception in 1997 and continues to contribute significantly to the medical community, as indicated by its Q2 ranking in Medicine (miscellaneous) for 2023 and its position in the top 15% of Scopus-ranked journals. The journal invites innovative studies, systematic reviews, and clinical trials, making it a critical resource for healthcare professionals, researchers, and students seeking to stay updated on the latest clinical practices. Based in the United Kingdom at Adam House, 3rd Fl, 1 Fitzroy Sq, London W1T 5HE, this journal supports open accessibility, enhancing the dissemination of vital research findings across the globe. Join the growing community of scholars who contribute to and benefit from this influential publication as it continues to shape the future of clinical practice.

The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.

JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, published by Elsevier Taiwan, stands as a significant academic resource in the field of medical research, particularly within the miscellaneous categories of medicine. With an impressive impact factor and categorized within the Q2 tier of medical journals, it boasts a commendable position in Scopus rankings—#63 out of 636 in General Medicine, placing it in the 90th percentile. Established initially in 1961 and evolving through its open access format since 2016, this journal fosters the dissemination of innovative research, serving an important role in the global medical community. Located in Taipei, Taiwan, it particularly emphasizes studies relevant to the Taiwanese population while welcoming international contributions, enhancing both local and global health discourse. As a trusted platform for researchers, professionals, and students alike, the journal aims to propel advancements in medical science and practice through high-quality peer-reviewed articles. ISSN: 0929-6646, E-ISSN: 1876-0821.

Frontiers in Medicine, published by FRONTIERS MEDIA SA, is a distinguished open-access journal that has been at the forefront of medical research since its inception in 2014. With an impressive 2023 Q1 ranking in the field of miscellaneous medicine and a notable Scopus rank of #93 out of 636—placing it in the 85th percentile in the general medicine category—this journal serves as a pivotal resource for academics and practitioners. Hailing from Switzerland, Frontiers in Medicine aims to publish high-quality research that addresses the most pressing issues in the medical field, fostering innovation and collaboration among researchers worldwide. By facilitating open access to comprehensive, peer-reviewed articles, the journal enhances the dissemination of knowledge and encourages interdisciplinary dialogues essential for medical advancement. Whether you're a researcher, a clinician, or a student, this journal is an invaluable tool for staying abreast of the latest developments in medicine.

ANNALS ACADEMY OF MEDICINE SINGAPORE is a reputable journal dedicated to the field of medicine, published by the Academy of Medicine, Singapore. With an E-ISSN of 2972-4066, this journal has been an influential platform since its inception in 1973, aiming to disseminate high-quality research and clinical findings pertinent to both local and international audiences. Currently ranked in the Q3 quartile in Medicine (miscellaneous), it holds a commendable 83rd percentile in Scopus rankings, indicating its significant academic contribution within the competitive landscape of medical literature. Although the journal operates on a traditional subscription-based model, it continues to provide access to critical insights that serve not only researchers but also healthcare professionals and students engaged in the ever-evolving medical sector. As it approaches its comprehensive publication mark in 2024, ANNALS will continue to focus on enhancing global healthcare discourse, making it an invaluable resource for those committed to advancing medical knowledge and practice.

The Lancet, established in 1823, is one of the most prestigious peer-reviewed journals in the field of medicine, published by Elsevier Science Inc. Renowned for its rigorous standards and commitment to high-quality research, this journal occupies a leading position in the academic world, holding an impressive Q1 category ranking in Medicine (miscellaneous) as of 2023, and ranking #1 out of 636 in the general medicine category with a remarkable 99th percentile according to Scopus. With an emphasis on global health, clinical practice, and medical policy, The Lancet aims to disseminate innovative research that pushes the boundaries of medical knowledge and informs practice worldwide. Although it does not currently offer Open Access options, its high impact factor and historical significance make it an essential resource for researchers, healthcare professionals, and students committed to advancing health and medicine. Engaging with this journal ensures staying at the forefront of critical developments in the medical field.

Caspian Journal of Internal Medicine, published by BABOL UNIVERSITY OF MEDICAL SCIENCES, serves as a significant platform for scholarly communication in the field of internal medicine. Established in 2010 and operating under an Open Access model, the journal aims to disseminate high-quality research findings and clinical insights to enhance the understanding of various internal medicine practices. With an ISSN of 2008-6164 and an E-ISSN of 2008-6172, this international journal has gained recognition, currently ranking in the Q3 category for internal medicine with a Scopus percentile of 38th, indicating its growing impact in the academic community. The journal publishes original research articles, review papers, and case reports, making it a valuable resource for researchers, healthcare professionals, and students eager to stay abreast of the latest developments in internal medicine. Situated in Iran, the journal aims to bridge gaps in knowledge and promote innovative practices in the healthcare sector. For those interested in contributing to the advancement of medicine, the Caspian Journal of Internal Medicine is a commendable choice.